Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $114.4700 (1.68%) ($112.4600 - $116.5100) on Tue. May. 21, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.6% (three month average) | RSI | 31 | Latest Price | $114.4700(1.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.3% a day on average for past five trading days. | Weekly Trend | LGND declines -3.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.3% in a week (0% probabilities). VXX(-21%) TLT(-15%) VIXM(-9%) IFRA(-8%) UUP(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.3% (StdDev 2.6%) | Hourly BBV | 0 () | Intraday Trend | 1.1% | | | |
|
1 - 5 Day Possible Target | $107.3(-6.26%) | Resistance Level | $119.75 | 5 Day Moving Average | $114.54(-0.06%) | 10 Day Moving Average | $115.37(-0.78%) | 20 Day Moving Average | $119.75(-4.41%) | To recent high | -11.5% | To recent low | 8.1% | Market Cap | $1.84b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |